|
Media Releases |
Financial Reports |
Presen-tations |
|
06/14/2007
|
|
|
|
| Lonza announces a worldwide price increase of 6 - 8 % for Niacin and Niacinmaide feed grade due to continued increases of raw materials, energy and transportation costs. |
The price increase will come into effect on 1 October 2007.
About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of pharmaceutical active ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SWX Swiss Exchange. In 2006 Lonza had sales of CHF 2.91 billion. Further information can be found at www.lonza.com.
For further information:
Ernesto Plozza
Business Unit Nutrition
Tel +41 61 316 8638
Fax +41 61 316 9638
ernesto.plozza@lonza.com
Corporate Communications
Margot Connor
Tel +41 61 316 8566
Fax +41 61 316 9566
Mobile +41 79 401 2832
margot.connor@lonza.com
|
|
|
